Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2025-12-25 @ 12:03 AM
NCT ID:
NCT04228458
Eligibility Criteria:
Inclusion Criteria:
Diagnosis of:
* Poly-articular JIA
* Oligo-articular JIA
* Psoriatic JIA
* Enthesitis-related JIA
Exclusion Criteria:
CYP below 4 years of age (pGALS is validated for school-age children and patients will be required to remain still during TI process)
Ongoing active/chronic infection requiring hospitalisation or treatment with intravenous antibiotics within 30 days of recruitment, or oral antibiotics within 14 days of recruitment
History of active tuberculosis of less than 6 months treatment or untreated latent tuberculosis
Soft tissue infection, injury or fracture of the affected joint which could confound the TI signature
Presence of any inflammatory skin condition (including, but not limited to Eczema and Psoriasis) which may be in close proximity to or overlying the joint
Presence of any other diagnosis which could cause arthritis including systemic-JIA (associated systemic inflammation may affect skin temperature independently of arthritis) or undifferentiated-JIA (excluded to ensure homogeneity of the sample investigated)
Non-English speaking patients and/or parent(s)/guardian(s)
Non-consenting CYP, or parent(s)/guardian(s)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Years
Maximum Age:
16 Years
Study:
NCT04228458
Study Brief:
Protocol Section:
NCT04228458